Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$52,524
-$2,105 QoQ
Shares Held
277
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,283
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bollard Group LLC holds $279,449,341 across 9 Drug Manufacturers - General names. AZN ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
197,160 | $236,479,638 | |
| 2 | MRK |
Merck & Co., Inc.
|
146,931 | $18,880,633 | |
| 3 | JNJ |
Johnson & Johnson
|
60,481 | $15,360,359 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
115,148 | $6,634,827 | |
| 5 | AMGN |
Amgen Inc
|
4,088 | $1,480,346 | |
| 6 | ABBV |
AbbVie Inc.
|
2,222 | $559,144 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
277 | $52,524 | |
| 8 | OGN |
Organon & Co.
|
138 | $1,868 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,524 | 277 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $54,629 | 277 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||